Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05210556 · ClinicalTrials.gov registry record
Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery
A clinical trial, sponsored by WellSpan Health.
- Completed
- Registry status
- 778
- Enrollment target
NCT05210556: Completed study, sponsored by WellSpan Health.
NCT05210556 is a clinical trial that has completed, run by WellSpan Health. The registered enrollment target is 778 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05210556 has completed, sponsored by WellSpan Health.
- COMPLETED
- Registry status
- 778 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.
Primary Outcome
Rate of surgical site infection rate as associated with or without use of antibiotic bowel preparation
Interventions
- OTHER Diagnosed with Surgical Site Infection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 778 participants |
| Start Date | 2021-12-22 |
| Est. Completion | 2024-06-30 |
What the finished NCT05210556 record still lists
NCT05210556 is an observational study that tracks outcomes without assigning an intervention. The registered 778 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Diagnosed with Surgical Site Infection is the first listed.
NCT05210556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05210556 about?
NCT05210556 is a clinical study titled "Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery". The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.
What is the current status of trial NCT05210556?
This trial is currently completed. The enrollment target is 778 participants. The study started on 2021-12-22. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05210556?
The interventions under investigation include: Diagnosed with Surgical Site Infection (OTHER).
Who is sponsoring clinical trial NCT05210556?
This trial is sponsored by WellSpan Health, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06841679 · 778 participants · Phase 2
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT05642611 · 777 participants · Phase 3
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI